共 126 条
[1]
Azadnajafabad S(2023)Evaluation of the diabetes care cascade and compliance with WHO global coverage targets in Iran based on STEPS survey 2021 Sci Rep 13 13528-2502
[2]
Ahmadi N(2017)Prevalence of cardiovascular disease in type 2 diabetes: A global systematic review Value Health 20 A475-893
[3]
Rezaei N(2016)Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes Mellitus - mechanisms, management, and clinical considerations Circulation 133 2459-890
[4]
Rashidi M-M(2017)Primary Prevention of cardiovascular disease in diabetes mellitus J Am Coll Cardiol 70 883-1001
[5]
Saeedi Moghaddam S(2018)Economic burden of cardiovascular disease in Type 2 diabetes: a systematic review Value in Health 21 881-22
[6]
Mohammadi E(2019)Lipid-lowering prescription patterns in patients with diabetes mellitus or cardiovascular disease Am J Cardiol 124 995-S174
[7]
Acs A(2012)Prescription pattern of Antihypertensive Agents in T2DM patients visiting Tertiary Care Centre in North India Int J Hypertens 2012 520915-3337
[8]
Ludwig C(2020)Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 Lancet 396 1204-329
[9]
Bereza BG(2021)10. Cardiovascular disease and risk management: standards of medical care in diabetes—2022 Diabetes Care 45 144-110
[10]
Einarson TR(2021)2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies with the special contribution of the European Association of Preventive Cardiology (EAPC) Eur Heart J 42 3227-1539